Crosstalk among dietary polyunsaturated fatty acids, urolithiasis, chronic inflammation, and urinary tract tumor risk

Nutrition

Volumn 29, Issue 7-8, 2013, Pages 930-938

  Eynard, Aldo R ^a   Navarro, Alicia ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Bladder cancer; Cystitis; Dietary lipids; PUFAs; Urinary calculi; Urinary Tract Tumors

Indexed keywords

CYTOKINE; POLYUNSATURATED FATTY ACID;

BIOACCUMULATION; CANCER CELL; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CELL SURFACE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HUMAN; LIPID PEROXIDATION; MOLECULAR PATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; SYNDROME DELINEATION; TISSUE CHARACTERIZATION; URINARY TRACT CANCER; URINARY TRACT TUMOR; UROLITHIASIS;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CHRONIC DISEASE; CYTOKINES; DIETARY FATS; DIETARY SUPPLEMENTS; FATTY ACIDS, UNSATURATED; HUMANS; INFLAMMATION; RISK FACTORS; URINARY TRACT; UROLITHIASIS; UROLOGIC NEOPLASMS;

EID: 84878978303     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.12.014     Document Type: Review

References (146)

1. Andreatta M.M., Navarro A., Eynard A.R. Urinary tract tumors, biology and risk for artificial sweeteners use with particular emphasis on some South American countries. Curr Nutr Food Sci 2008, 4:1-11.
2. Andreatta M.M., Navarro A., Muñoz S.E., Aballay L., Eynard A.R. Dietary Patterns and Food Groups are linked to the risk of Urinary Tract Tumors in Argentina. Eur J Cancer Prev 2010, 19:478-484.
3. Hicks R.M. The mammalian urinary bladder: an accommodating organ. Biol Rev Camb Philos Soc 1975, 50:215-246.
4. Eynard A.R. Is the risk of urinary tract tumorigenesis enhanced by a marginal chronic essential fatty acid deficiency (EFAD)?. Nutrition 1998, 14:211-216.
5. Andreatta M.M., Muñoz S.E., Lantieri M.J., Eynard A.R., Navarro A. Artificial sweeteners consumption and risk for urinary tract tumours in Córdoba, Argentina. Prev Med 2008, 47:136-139.
6. Diaz M.P., Osella A.O., Aballay L., Muñoz S.E., Lantieri M.J., Butinof M., et al. Cancer incidence pattern in Cordoba, Argentina. Eur J Cancer Prev 2009, 18:259-266.
7. World Health Organization Report on the global tobbaco epidemic, 2009. Implementing smoke-free environments 2009, WHO, Geneve, Switzerland.
8. Czene K., Tiikkaja S., Hemminki K. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer 2003, 105:108-112.
9. Bruyere F., Traxer O., Saussine C., Lechevallier E. Infection and urinary lithiasis. Prog Urol 2008, 18:1015-2100.
10. Gutierrez J., Smith A., Geavlete P., Shah H., Kural A.R., de Sio M., et al. Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol 2012 Feb 25, [Epub ahead of print] PMID:22367718.
11. Chen H.S., Su L.T., Lin S.Z., Sung F.C., Ko M.C., Li C.Y. Increased risk of urinary tract calculi among patients with diabetes mellitus. A population-based cohort study. Urology 2012, 79:86-92.
12. De Stefani E., Boffetta P., Ronco A.L., Deneo-Pellegrini H., Acosta G., Mendilaharsu M. Dietary patterns and risk of bladder cancer: a factor analysis in Uruguay. Cancer Causes Control 2008, 19:1243-1249.
13. Andreatta M.M., Eynard A.R., Navarro A. Alcohol, diet and their interaction in colorectal and urinary tract tumors. Alcohol, nutrition, and health consequences 2012, 33:429-437. Humana Press, Springer, New York. R.R. Watson (Ed.).
14. Hopcnhayn-Rich C., Biggs M.L., Fuchs A., Bergoglio R., Tello E.E., Nicolli H., et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1966, 7:117-124.
15. Marshall G., Ferreccio C., Yuan Y., Bates M.N., Steinmaus C., Selvin S., et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 2007, 99:920-928.
16. Aballay L.R., Dìaz M.P., Francisca M.T., Muñoz S.E. Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina. Int J Environ Health Res 2012, 22:220-221.
17. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 2001, 153:411-418.
18. Cremonezzi D.C., Díaz M.P., Valentich M.A., Eynard A.R. Neoplastic and preneoplastic lesions induced by melamine in rat urothelium are modulated by dietary polyunsaturated fatty acids. Food Chem Toxicol 2004, 42:1999-2007.
19. Cremonezzi D.C., Silva R.A., Díaz M.P., Valentich M.A., Eynard A.R. Dietary polyunsaturated fatty acids (PUFA) differentially modulate melamine-induced preneoplastic urothelial proliferation and apoptosis in mice. Prostaglandins Leukot Essent Fatty Acids 2001, 151:159-164.
20. Vara-Messler M., Cremonezzi D.C., Soria E.A., Eynard A.R. Nutritional chemoprevention of urinary tract tumors (UTT) induced by lithogenic agents: risk for UTT in children exposed to melamine-contaminated milk formulae. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2012, 30:174-187.
21. Pelucchi C., Bosetti C., Negri E., Malvezzi M., La Vecchia C. Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol 2006, 3:327-340.
22. Dominick M.A., White M.R., Sanderson T.P., Van Vleet T., Cohen S.M., Arnold L.E., et al. Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: evidence for urolithiasis as the inciting event in the mode of action. Toxicol Pathol 2006, 34:903-920.
23. Cui L., Shi Y., Qian J., Dai G., Wang Y., Xia Y., et al. Deregulation of the p16-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway involved in the rat bladder carcinogenesis induced by terephthalic acid-calculi. Urol Res 2006, 34:321-328.
24. Navarro A., Muñoz S.E., Lantieri M.J., Diaz M.P., Cristaldo P., de Fabro S.P., et al. Meat cooking habits and risk of colorectal cancer in Cordoba, Argentina. Nutrition 2004, 20:873-877.
25. Cantrill R.C., Huang Y.S. Fatty acids and cancer. Nutrition 1998, 14:235-236.
26. Hu J., La Vecchia C., de Groh M., Negri E., Morrison H., Mery L. Dietary trans fatty acids and cancer risk. Eur J Cancer Prev 2011, 20:530-538. the Canadian Cancer Registries Epidemiology Research Group.
27. Brinkman M.T., Karagas M.R., Zens M.S., Schned A.R., Reulen R.C., Zeegers M.P. Intake of α-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case-control study. Br J Nutr 2011, 106:1070-1077.
28. Eynard A.R. Role of dietary polyunsaturated fatty acids (PUFA) on tumorigenesis. Cancer J 1996, 9:142-144.
29. Eynard A.R. Does chronic essential fatty acid deficiency (EFAD) constitute a protumorigenic condition?. Med Hypoth 1997, 48:55-62.
30. Monis B., Eynard A.R. Incidence of urothelial tumors in essential fatty acid deficient rats. J Natl Cancer Inst 1980, 64:73-79.
31. Monis B., Eynard A.R. Abnormal cell proliferation and differentiation and urothelial tumorigenesis in essential fatty acid deficient (EFAD) rats. Prog Lip Res 1981, 20:691-703.
32. Zhang X., Zhao C., Jie B. 2010. Various dietary polyunsaturated fatty acids modulate acrylamide-induced preneoplatic urothelial proliferation and apoptosis in mice. Exp Toxicol Pathol 2010, 62:9-16.
33. Baggio B., Gambaro G., Zambon S., Marchini F., Bassi A., Bordin L., et al. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis. J Am Soc Nephrol 1996, 7:613-620.
34. Kajikawa H. The influence of dietary lipids on nephrolithiasis in rats. Nihon Hinyokika Gakkai Zasshi 1998, 89:931-938.
35. Yasui T., Tanaka H., Fujita K., Iguchi M., Kohri K. Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers. Eur Urol 2001, 39:580-585.
36. Sorensen M.D., Kahn A.J., Reiner A.P., Tseng T.Y., Shikany J.M., Wallace R.B., et al. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol 2012, 187:1645-1649.
37. Das U.N. Metabolic syndrome pathophysiolgy: the role of essenctial fatty acids 2010, Wiley-Blackwell, Singapore.
38. Das U.N. Molecular basis of health and disease. Dordrecht 2011, Springer, Heilderber, Germany.
39. Mead J.F. The essential fatty acids: past, present, future. Prog Lipid Res 1981, 20:1-6.
40. Navarro A., Osella A.R., Muñoz S.E., Lantieri M.J., Fabro E.A., Eynard A.R. Fatty acids, fibres and colorectal cancer risk in Córdoba, Argentina. J Epidemiol Biostatistics 1998, 3:415-422.
41. Navarro A., Diaz M.P., Muñoz S.E., Lantieri M.J., Eynard A.R. Characterization of meat consumption and risk of colorectal cancer in Cordoba, Argentina. Nutrition 2003, 19:7-10.
42. Nakayama M., Ju H.R., Sugano M., Hirose N., Ueki T., Doi F., et al. Effect of dietary fat and cholesterol on dimethyl- benz (a) anthracene- induced mammary tumorigenesis in Sprague- Dawley rats. Anticancer Res 1993, 13:691-698.
43. Nguyen T.T., Ziboh V.A., Uematsu S., McCullough J.L., Weinstein G. New model of a scaling dermatosis: induction of hyperproliferation in hairless mice with eicosa-5,8,11-trienoic acid. J Invest Dermatol 1981, 76:384-387.
44. Lagarde M., Burtin M., Rigaud M., Sprecher H., Dechavanne M., Renaud S. Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. FEBS Lett 1985, 181:53-56.
45. Calderon R.O., Eynard A.R. Fatty acids specifically related to the anisotropics properties of plasma membrane from rat urothelium. BBActa 2000, 1483:174-184.
46. Eynard A.R., Monis B. Concanavalin A sites in urothelium and milk fat globules of essential fatty acid (EFA) deficient rats. J Submicros Cytol 1983, 15:375-382.
47. Kim W., Khan N.A., McMurray D.N., Prior I.A., Wang N., Chapkin R.S. Regulatory activity of polyunsaturated fatty acids in T-cell signaling. Prog Lipid Res 2010, 49:250-261.
48. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012, 36:764-785.
49. Min G., Schapira M., Sun T.T., Kong X.P. Structural basis of urothelial permeability barrier function as revealed by Cryo-EM 470 studies of the 16 nm uroplakin particle. J Cell Sci 2003, 116:4087-4094.
50. Bongiovanni G., Eynard A.R., Calderón R.O. Altered lipid profile and changes in uroplakin properties of rat urothelial plasma membrane with diets of different lipid composition. Mol Cell Biochem 2005, 271:69-75.
51. Calderón R.O., Grasso E.J. Symmetric array of the urothe lium surface controlled by the lipid lattice composition. Biochem Biophys Res Commun 2006, 339:642-646.
52. Wassall S.R., Stillwell W. Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes. Biochim Biophys Acta 2009, 1788:24-32.
53. Raza Shaikh S., Brown D.A. Models of plasma membrane organization can be applied to mitochondrial membranes to target human health and disease with polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013, 88:21-25.
54. Gilroy D.W., Newson J., Sawmynaden P., Willoughby D.A., Croxtall J.D. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J 2004, 18:489-498.
55. Serra-Majem L., Nissensohn M., Øverby N.C., Fekete K. Dietary methods and biomarkers of omega 3 fatty acids: a systematic review. Br J Nutr 2012, 107(suppl 2):S64-S76.
56. Pasqualini M.E., Berra M.A., Yurawecz M.P., Repossi G., Eynard A.R. Dietary manipulation of precursor polyunsaturated fatty acids modulates eicosanoid and endocanabinoid synthesis: a potential tool to control tumor development. Curr Nutr Food Sci 2008, 4:161-175.
57. Basselin M., Ramadan E., Rapoport S.I. Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans. Brain Res Bull 2012, 87:154-171.
58. Mourek J., Mourek J. Developmentally dependent and different roles of fatty acids w6 and w3. Prague Med Rep 2011, 112:81-92.
59. Pasqualini M.E., Berra M.A., Calderón R.O., Cremonezzi D.C., Giraudo C., Eynard A.R. Dietary lipids modulate eicosanoid release and apoptosis of cells of a murine lung alveolar carcinoma. Prostag Leuk Essent fatty Acids 2005, 72:235-240.
60. Eynard A.R. Potential of essential fatty acids as natural therapeutic products for human tumors. Nutrition 2003, 19:387-388.
61. Das U.N. Infection, inflammation and polyunsaturated fatty acids. Nutrition 2011, 10:1080-1084.
62. Van den Elsen L., Garssen J., Willemsen L. Long chain N-3 polyunsaturated fatty acids in the prevention of allergic and cardiovascular disease. Curr Pharm Des 2012, 18:2375-2392.
63. Aballay L.R., Díaz M.P., Navarro A., Eynard A.R., Muñoz S.E. Overweight and obesity in South America: a critical overview and their relationship to metabolic syndrome, cardiovascular diseases and cancer. Nutr Cancer 2012, in press. http://dx.doi.org/10.1111/J.1753-4887.2012.00533.x.
64. Horrobin D.F. Essential fatty acids, lipid peroxidation and cancer. Omega 6 essentiel fatty acids: pathophysiology and roles in clinical medicine 1990, 351-377. Alan Liss, New York. F.D. Horrobin (Ed.).
65. Wang X., Lin H., Gu Y. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis 2012, 11:25-31.
66. Santos C.R., Schulze A. Lipid metabolism in cancer. FEBS J 2012, 279:2610-2623.
67. Gerber M. Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 2012, 107(suppl 2):S228-S239.
68. Hicks R.M. The function of Golgi complex in transitional epithelium. J Cell Biol 1966, 30:623-635.
69. Kachar B., Liang F., Lins U., Ding M., Wu X.R., Stoffler D., et al. Three-dimensional analysis of the 16 nm urothelial plaque particle: luminal surface exposure, preferential head-to-head interaction, and hinge formation. J Mol Biol 1999, 285:595-608.
70. Hu P., Deng F.M., Lian F.X., Hu C.M., Auerbach A., Shapiro E., et al. Ablation of uroplakin III gene result in small urothelial plaques urothelial leakage and vesico- ureteral reflux. J Cell Biol 2000, 151:961-971.
71. Truschel S.T., Wang E., Ruiz W.G., Leung S.M., Rojas R., Lavelle J., et al. Stretch-regulated exocytosis/endocytosis in bladder umbrella cells. Mol Biol Cell 2002, 13:830-846.
72. Clemow D., Steers W., Tuttle J. Stretch-regulated signalling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive, and hyperactive rats. J Cell Physiol 2000, 183:289-300.
73. Lewis S.A. Everything you wanted to know about the bladder epithelium but were afraid to ask. American J Physiol 2000, 278:F867-F874.
74. Wasungu L., Stuart M.C.A., Scarzello M., Engberts J.B.F.N., Hoekstra D. Lipoplexes formed from sugar-based Gemini surfactants undergo a lamellar-to-micellar phase transition at acidic pH. Evidence for a non-inverted membrane-destabilizing hexagonal phase of lipoplexes. Biochim Biophys Acta 2006, 1758:1677-1684.
75. Hoilund L.J., Sundberg D.R., Herbst G., Parkin J.D. Essential fatty acid deficiency in the rat. I. Clinical syndrome, histopathology and hematopathology. Lab Invest 1970, 23:58-70.
76. Kyriakides E.C., Beeler D.A., Edmonds R.H., Balint J.A. Alterations in phosphatidylcholine species and their reversal in pulmonary surfactant during essential fatty acid deficiency. Biochem Biophys Acta 1976, 431:339-407.
77. Chlapowski F.J., Bonneville M.A., Staehelin L.A. Lumnenal plasma membrane of the urinary bladder. II. Isolation and structure of membrane components. J Cell Biol 1972, 53:92-104.
78. Ketterer B., Hicks R.M., Christodoulides L., Beale D. Studies of the chemistry of luminal plasma membrane of rat bladder epithelial cells. Biochim Biophys Acta 1973, 311:180-190.
79. Koss L.G. Some ultrastructural aspects of experimental and human carcinoma of the bladder. Cancer Res 1977, 37:2824-2835.
80. Eynard A.R., Jiang W.G., Mansel R.E. Eicosatrienoic acid (20:3 n-9) inhibits the expression of e-cadherin and desmoglein in human squamous cell carcinoma (SCC) invitro. Prostagl Leuk Essential Fatty Acids 1998, 59:371-377.
81. Jiang W.G., Redfern A., Eynard A.R., Mansel R.E. Polyunsaturated fatty acids and their role in cancer invasion and metastasis. Cancer metastasis, molecular and cellular mechanisms andclinical intervention 2000, 225-250. Kluwer Academic Publishers, Amsterdam, Netherlands. W.G. Jiang, R.E. Mansel (Eds.).
82. Jiang W.G., Eynard A.R., Mansel R.E. The pathology of essential fatty acid (EFA) deficiency is it cell adhesion mediated?. Med Hypoth 2000, 55:257-262.
83. Heyd V., Eynard A.R. Effects of eicosatrienoic acid (20:3 n-9, Mead's acid) on some promalignant-related properties of three human cancer cell lines. Prostagl Other Lip Med 2003, 71:177-188.
84. Sicard B., Lagarde M. Incorporation of some eicosanoic acids into endothelial cells-effect on platelet inhibitory activity and prostacyclin production. Thromb Haemost 1985, 53:264-267.
85. Nakano N., Shirasaka N., Kurihara M., Takamatsu M., Murakami T., Yoshizumi H., et al. Competitive incorporation of arachidonic acid analogs by cultured rat keratinocytes. J Nutr Sci Vitaminol (Tokyo) 2001, 47:69-77.
86. Calderon R.O., Glocker M.T., Eynard A.R. Lipids and fatty acid composition of different fractions from rat urinary transitional epithelium. Lipids 1998, 33:1017-1022.
87. Fermor B.F., Masters J.R.W., Wood C.B., Miller J., Apostolov K., Habib N.A. Fatty acid composition of normal and malignant cells and cytotoxicity of stearic, oleic and sterculic acids invitro. Eur J Cancer 1992, 28A:1143-1147.
88. Grasso E.J., Calderón R.O. Urinary bladder membrane permeability differentially induced by membrane lipid composition. Mol Cell Biochem 2009, 330:163-169.
89. Grasso E.J., Scalambro M.B., Calderón R.O. Differential response of the urothelial V-ATPase activity to the lipid environment. Cell Biochem Biophys 2011, 61:157-168.
90. Dontas I.A., Khaldi L. Urolithiasis and transitional cell carcinoma of the bladder in a Wistar rat. J Am Assoc Lab Anim Sci 2006, 45:64-67.
91. Radomski J.L., Krischer C., Krischer K.N. Histologic and histochemical preneoplastic changes in the bladder mucosae of dogs given 2-naphthylamine. J Natl Cancer Inst 1978, 60:327-333.
92. Cohen S.M. Comparative pathology of proliferative lesions of the urinary bladder. Toxicol Pathol 2002, 30:663-671.
93. Monis B., Eynard A.R., Lis D., Kalinec F. Ultrastructural changes of the luminal plasma membrane of the rat urinary tract in essential fatty acid deficiency. Experientia 1976, 32:697-699.
94. Monis B., Eynard A.R., Kalinec F., Valentich M.A., Parlanti I.A. Recent observations on the pathobiology of essential fatty acid deficient rats. Curr Top Nutr Dis 1981, 5:179-195.
95. Burr G.O., Burr M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 1929, 82:345-350.
96. Burr G.O., Burr M.M. On the nature and role of the fatty acids essential in nutrition. J Biol Chem 1930, 86:587-594.
97. Borland V.G., Jackson C.M. Effects of a fat-free diet on the structure of the kidneys in rats. Arch Pathol 1931, 11:687-692.
98. Toriyama-Baba H., Ligo M., Asamoto M., Iwahori H., Park C.B., Han B.S., et al. Organotropic chemopreventive effects of n-3 unsaturated fatty acids inarat multi-organ carcinogenesis model. Jpn J Cancer Res 2001, 92:1175-1183.
99. Federico A., Morgillo F., Tuccillo C., Ciardiello F., Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007, 121:238-246.
100. Chapkin R.S., Kim W., Lupton J.R., McMurray D.N. Dietary docosahexaenoic and eicosapentaenoic acid: Emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009, 81:187-191.
101. Dinarello C.A. Why not treat human cancer with interleukin-1 blockade?. Cancer Metastasis Rev 2010, 29:317-329.
102. Demaría S., Pikarsky E., Karin M., Coussens L.M., Chen Y.C., El-Omar E.M., et al. Cancer and inflammation: promise for biologic therapy. J Inmunother 2010, 33:335-351.
103. Das U.N. Can cancer cachexia be prevented/treated?. Nutrition 2012, 28:844-848.
104. Shi Y., Cui L., Dai G., Chen J., Pan H., Song L., et al. Elevated prostaglandin E2 level via cPLA2-COX-2-mPGES-1 pathway involved in bladder carcinogenesis induced by terephthalic acid-calculi in Wistar rats. Prostaglandins Leukot Essent Fatty Acids 2006, 74:309-315.
105. Chung S.D., Liu H.T., Lin H., Kuo H.C. Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 2011, 30:417-420.
106. Das U.N. Essential fatty acids-a review. Curr Pharm Biotechnol 2006, 7:467-482.
107. Das U.N. Free radicals: biology and relevance to disease. J Assoc Physicians India 1990, 38:495-498.
108. Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. Br Med Bull 1993, 49:481-493.
109. Pani G., Galeotti T., Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 2010, 29:351-378.
110. Das U.N., Begin M.E., Ells G., Huang Y.S., Horrobin D.F. Polyunsaturated fatty acids augment free radical generation in tumor cells invitro. Biochem Biophys Res Commun 1987, 145:15-24.
111. McClinton S., Moffat L.E., Horrobin D.F., Manku M.S. Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer 1991, 63:314-331.
112. Horrobin D.F. Is the main problem in free radical damage caused by radiation, oxygen and other toxins the loss of membrane essential fatty acids rather than the accumulation of toxic materials?. Med Hypotheses 1991, 35:23-26.
113. Riboli E., González C.A., López-Abente G., Errezola M., Izarzugaza I., Escolar A., et al. Diet and bladder cancer in Spain: a multi-centre case-control study. Int J Cancer 1991, 49:214-219.
114. González C.A., Errezola M., Izarzugaza I., López-Abente G., Escolar A., Nebot M., et al. Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer 1991, 27:498-500.
115. Baena A.V., Allam M.F., Del Castillo A.S., Díaz-Molina C., Requena Tapia M.J., Abdel-Rahman A.G., et al. Urinary bladder cancer risk factors in men: a Spanish case-control study. Eur J Cancer Prev 2006, 15:498-503.
116. International Agency for Research on Cancer IARC monographs on the Evaluation of Carcinogenic Risks to Humans. Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances. Melamine 1999, 73. IARC, Lyon, France, p. 329-333.
117. Ogasawara H., Imaida K., Ishiwata H., Toyoda K., Kawanishi T., Uneyama C., et al. Urinary bladder carcinogenesis induced by melamine in F344 male rats: correlation between carcinogenicity and urolith formation. Carcinogenesis 1995, 16:2773-2777.
118. Burin G.J., Gibb H.J., Hill R.N. Human bladder cancer: evidence for a potential irritation-induced mechanism. Food Chem Toxicol 1995, 33:785-795.
119. Steinmaus C.M., Nuñez S., Smith A.H. Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 2000, 151:693-702.
120. Stocco B., Toledo K., Salvador M., Paulo M., Koyama N., Torqueti Toloi M.R. Dose-dependent effect of resveratrol on bladder cancer cells: chemoprevention and oxidative stress. Maturitas 2012, 72:72-78.
121. Moussa O., Ciupek A., Watson D.K., Halushka P.V. Urinary thromboxane B2 and thromboxane receptors: opportunity for detection and monitoring. Prostaglandins Other Lipid Mediat 2011, 96:41-44.
122. Eruslanov E., Daurkin I., Vieweg J., Daaka Y., Kusmartsev S. Aberrant PGE, metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells. Int Immunopharmacol 2011, 11:848-855.
123. Aaes-Jorgensen E. Essential fatty acids. Physiol Rev 1961, 41:1-51.
124. Alfin-Slater R.B., Bernick S. Changes in tissue lipids and tissue histology resulting from essential fatty acid deficiency in rats. Am J Clin Nutr 1958, 6:613-624.
125. Panos T.C., Finerty J.C. Effects of a fat-free diet on growing male rats with special reference to the endocrine system. J Nutr 1954, 4:315-319.
126. Das U.N. Can essential fatty acids reduce the burden of disease(s)?. Lipids Health Dis 2008, 7:9.
127. Oberbach A., Schlichting N., Blüher M., Kovacs P., Till H., Stolzenburg J.U., et al. Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections. PLoS ONE 2010, 5:e10882.
128. Shirai T., Ikawa E., Fukushima S., Masui T., Ito N. Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats. Cancer Res 1986, 46:2062-2067.
129. Moblet T.L., Coyle J.K., Al-Hussaini M., McDonald D.F. The role of chronic mechanical irritation in experimental urothelial tumorigenesis. Invest Urol 1966, 3:325-333.
130. Wakefield J.S., Hicks R.M. Erythrophagocytosis by the epithelial cells of the bladder. J Cell Sci 1974, 15:555-573.
131. Sarach M.A., Rovasio R.A., Eynard A.R. Platelet factors induce chemotactic migration of mammary adenocarcinoma cells with different metastatic capabilities. Int J Exp Pathol 1993, 74:511-517.
132. Pasqualini M.E., Heyd V., Manzo P., Eynard A.R. Association between e-cadherin expression by human colon, bladder and breast cancer cells and the 13-HODE: possible role of their metastasic pottential. Prostagl Leuk Essential Fatty Acids 2003, 68:9-16.
133. Evans J., Salamonsen L.A. Inflammation, leukocytes and menstruation. RevEndocr Metab Disord 2012, 13(4):277-288. 10.1007/s11154-012-9223-7.
134. Macedo F.Y., Mourão L.T., Palheta R.C., Jucá D.M., Lima R.C., Neto Jde S., et al. Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder. Cancer Chemother Pharmacol 2010, 67:935-943.
135. Macedo F.Y., Mourão L.T., Freitas H.C., Lima R.C., Wong D.V., Oriá R.B., et al. Interleukin-4 modulates the inflammatory response in ifosfamide-induced hemorrhagic cystitis. Inflammation 2012, 35:297-307.
136. Tan A.C., Konczak I., Sze D.M., Ramzan I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr Cancer 2011, 63:495-505.
137. Zeegers M.P.A., Kellen E., Buntinx F., Van den Brandt P.A. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004, 21:392-401.
138. Xin H., Stone R. Tainted milk scandal: Chinese probe unmasks high-tech adulteration with melamine. Science 2008, 322:1310-1311.
139. Bhalla V., Grimm P.C., Chertow G.M., Pao A.C. Melamine nephrotoxicity: anemerging epidemic in an era of globalization. Kidney Int 2009, 75:774-779.
140. Tyan Y.C., Yang M.H., Jong S.B., Wang C.K., Shiea J. Melamine contamination. Anal Bioanal Chem 2009, 395:729-735.
141. Melnick R.L., Boorman G.A., Haseman J.K., Montali R.J., Huff J. Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol Appl Pharmacol 1984, 72:292-303.
142. Keibel A., Singh V., Sharma M.C. Inflammation, microenvironment, and the immune system in cancer progression. Curr Pharm Des 2009, 15:1949-1955.
143. Sinclair H.M. Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet 1956, 270:381-383.
144. Holman R.T. How essential are essential fatty acids?. J Am Med Assoc 1961, 178:930-936.
145. Soria E.A., Eynard A.R., Bongiovanni G.A. Cytoprotective effects of silymarin on epithelial cells against arsenic-induced apoptosis in contrast with quercetin cytotoxicity. Life Sciences 2010, 87:309-315.
146. Comba A., Lin Y.H., Eynard A.R., Valentich M.A., Fernandez-Zapico M.E., Pasqualini M.E. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev 2011, 30:325-342.